Pharmaceuticals

Drug Discovery Market Trends 2025–2029: Forecasts for Key Growth Segments

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Drug Discovery Market Over The Five-Year Period 2025–2029?

The drug discovery market size has seen substantial growth recently. It is forecast to expand from $110.26 billion in 2024 to $124.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.6%. This historical expansion can be attributed to advancements in genomics and proteomics, the increasing prevalence of chronic diseases, and the emergence of biopharmaceuticals.

The drug discovery market size is projected to experience rapid growth in the upcoming years, expanding to $217.01 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is attributed to factors like the adoption of precision medicine, a heightened focus on rare diseases, and the proliferation of personalized therapies. Key trends expected over the forecast period include collaborative drug discovery models, a strong emphasis on rare diseases and orphan drugs, the integration of multi-omics data, the swift adoption of organoids and 3D cell culture models, and advancements in virtual screening methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Are The Main Drivers Boosting The Drug Discovery Industry’s Expansion?

The drug discovery market is expected to be invigorated by increasing healthcare spending in the coming years. Globally, countries dedicate a substantial portion of their GDP to various healthcare costs, which encompass hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, and other related expenses. Drug discovery represents a significant segment of this health expenditure, as it is essential for treating diseases and extending human life. There is a growing demand for novel pharmaceutical agents to address new illnesses. For instance, in October 2024, data from the Centers for Medicare and Medicaid Services, a federal agency based in the US, indicated that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, or $13,493 per person. Furthermore, for the period 2023–32, the average national health expenditure growth (5.6%) is projected to surpass the average GDP growth (4.3%), which will lead to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, this escalation in healthcare expenditures is a key factor driving the expansion of the drug discovery market.

What Are The Emerging Segments Gaining Attention In The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

How Are Trends Influencing The Drug Discovery Market?

Significant progress in technology represents a primary trend within the drug discovery market. Firms engaged in the drug discovery market are introducing diverse novel technologies, including AI and imaging technology, among others, with the aim of shortening the drug discovery timeline. Imaging technology facilitates the non-intrusive visualization, characterization, and quantification of biological processes happening inside organisms in reaction to drugs. These approaches, leveraging the advantages of either probes or the tissue itself, are vital for comprehending illnesses and identifying novel therapeutic options. For example, in May 2023, Google Cloud unveiled two innovative AI-driven tools, the Target and Lead Identification Suite and the Multiomics Suite, designed to speed up drug discovery and advance precision medicine. The purpose of these tools is to assist biotechnology and pharmaceutical enterprises in furthering drug discovery and precision medicine efforts. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, whereas the Multiomics Suite hastens the discovery and understanding of genomic data, thereby contributing to the development of tailored treatments.

Who Are The Major Companies Operating In The Drug Discovery Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Geographies Are Emerging As Strong Markets For The Drug Discovery Industry?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Laboratory Automation Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/laboratory-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795